866-997-4948(US-Canada Toll Free)

United States Recombinant Protein Drugs Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 106 Pages

Notes:
Sales, means the sales volume of Recombinant Protein Drugs
Revenue, means the sales value of Recombinant Protein Drugs

This report studies sales (consumption) of Recombinant Protein Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Recombinant Protein Drugs in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Recombinant Protein Drugs Market Report 2017
1 Recombinant Protein Drugs Overview
1.1 Product Overview and Scope of Recombinant Protein Drugs
1.2 Classification of Recombinant Protein Drugs
1.2.1 Type I
1.2.2 Type II
1.3 Application of Recombinant Protein Drugs
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Recombinant Protein Drugs (2012-2022)
1.4.1 United States Recombinant Protein Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)

2 United States Recombinant Protein Drugs Competition by Manufacturers
2.1 United States Recombinant Protein Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Recombinant Protein Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Recombinant Protein Drugs Average Price by Manufactures (2015 and 2016)
2.4 Recombinant Protein Drugs Market Competitive Situation and Trends
2.4.1 Recombinant Protein Drugs Market Concentration Rate
2.4.2 Recombinant Protein Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Recombinant Protein Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Recombinant Protein Drugs Sales and Market Share by States (2012-2017)
3.2 United States Recombinant Protein Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Recombinant Protein Drugs Price by States (2012-2017)

4 United States Recombinant Protein Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Recombinant Protein Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Recombinant Protein Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Recombinant Protein Drugs Price by Type (2012-2017)
4.4 United States Recombinant Protein Drugs Sales Growth Rate by Type (2012-2017)

5 United States Recombinant Protein Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Recombinant Protein Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Recombinant Protein Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Recombinant Protein Drugs Manufacturers Profiles/Analysis
6.1 Novo Nordisk
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Recombinant Protein Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Novo Nordisk Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Amgen
6.2.2 Recombinant Protein Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Amgen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Sanofi
6.3.2 Recombinant Protein Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Eli Lilly
6.4.2 Recombinant Protein Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Eli Lilly Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merck Serono
6.5.2 Recombinant Protein Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck Serono Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Ortho Biotech
6.6.2 Recombinant Protein Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Ortho Biotech Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Roche
6.7.2 Recombinant Protein Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Roche Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Kyowa Hakko Kirin
6.8.2 Recombinant Protein Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Pharmingen
6.9.2 Recombinant Protein Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Pharmingen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Abcam
6.10.2 Recombinant Protein Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Abcam Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 GenSci
6.12 SL PHARM
6.13 Dongbao Pharm
6.14 Ankebio
6.15 NCPC
6.16 Heng Rui

7 Recombinant Protein Drugs Manufacturing Cost Analysis
7.1 Recombinant Protein Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Protein Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Recombinant Protein Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Recombinant Protein Drugs Market Forecast (2017-2022)
11.1 United States Recombinant Protein Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Recombinant Protein Drugs Sales Forecast by Type (2017-2022)
11.3 United States Recombinant Protein Drugs Sales Forecast by Application (2017-2022)
11.4 Recombinant Protein Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Recombinant Protein Drugs
Table Classification of Recombinant Protein Drugs
Figure United States Sales Market Share of Recombinant Protein Drugs by Type in 2015
Table Application of Recombinant Protein Drugs
Figure United States Sales Market Share of Recombinant Protein Drugs by Application in 2015
Figure United States Recombinant Protein Drugs Sales and Growth Rate (2012-2022)
Figure United States Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Table United States Recombinant Protein Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Recombinant Protein Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Protein Drugs Sales Share by Manufacturers
Figure 2016 Recombinant Protein Drugs Sales Share by Manufacturers
Table United States Recombinant Protein Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Recombinant Protein Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Recombinant Protein Drugs Revenue Share by Manufacturers
Table 2016 United States Recombinant Protein Drugs Revenue Share by Manufacturers
Table United States Market Recombinant Protein Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Recombinant Protein Drugs Average Price of Key Manufacturers in 2015
Figure Recombinant Protein Drugs Market Share of Top 3 Manufacturers
Figure Recombinant Protein Drugs Market Share of Top 5 Manufacturers
Table United States Recombinant Protein Drugs Sales by States (2012-2017)
Table United States Recombinant Protein Drugs Sales Share by States (2012-2017)
Figure United States Recombinant Protein Drugs Sales Market Share by States in 2015
Table United States Recombinant Protein Drugs Revenue and Market Share by States (2012-2017)
Table United States Recombinant Protein Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Recombinant Protein Drugs by States (2012-2017)
Table United States Recombinant Protein Drugs Price by States (2012-2017)
Table United States Recombinant Protein Drugs Sales by Type (2012-2017)
Table United States Recombinant Protein Drugs Sales Share by Type (2012-2017)
Figure United States Recombinant Protein Drugs Sales Market Share by Type in 2015
Table United States Recombinant Protein Drugs Revenue and Market Share by Type (2012-2017)
Table United States Recombinant Protein Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Protein Drugs by Type (2012-2017)
Table United States Recombinant Protein Drugs Price by Type (2012-2017)
Figure United States Recombinant Protein Drugs Sales Growth Rate by Type (2012-2017)
Table United States Recombinant Protein Drugs Sales by Application (2012-2017)
Table United States Recombinant Protein Drugs Sales Market Share by Application (2012-2017)
Figure United States Recombinant Protein Drugs Sales Market Share by Application in 2015
Table United States Recombinant Protein Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Protein Drugs Sales Growth Rate by Application (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Merck Serono Basic Information List
Table Merck Serono Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Serono Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Ortho Biotech Basic Information List
Table Ortho Biotech Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ortho Biotech Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Kyowa Hakko Kirin Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Pharmingen Basic Information List
Table Pharmingen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pharmingen Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Abcam Basic Information List
Table Abcam Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abcam Recombinant Protein Drugs Sales Market Share (2012-2017)
Table GenSci Basic Information List
Table SL PHARM Basic Information List
Table Dongbao Pharm Basic Information List
Table Ankebio Basic Information List
Table NCPC Basic Information List
Table Heng Rui Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Protein Drugs
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Figure Recombinant Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2015
Table Major Buyers of Recombinant Protein Drugs
Table Distributors/Traders List
Figure United States Recombinant Protein Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Recombinant Protein Drugs Production Forecast by Type (2017-2022)
Table United States Recombinant Protein Drugs Consumption Forecast by Application (2017-2022)
Table United States Recombinant Protein Drugs Sales Forecast by States (2017-2022)
Table United States Recombinant Protein Drugs Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *